{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Waco",
      "state": "TX",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "72016",
      "recalling_firm": "Allergan Sales, LLC",
      "address_1": "8301 Mars Dr",
      "address_2": "N/A",
      "postal_code": "76712-6578",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "N/A",
      "distribution_pattern": "Nationwide, Puerto Rico, and Barbados",
      "recall_number": "D-1820-2015",
      "product_description": "BLEPHAMIDE (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10 %/0.2 %, 3.5 g tube, Rx only, ALLERGAN, Irvine, California  92612, NDC 0023-0313-04, UPC 3 00230 31304 9.",
      "product_quantity": "337 tubes",
      "reason_for_recall": "Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially introducing the particle into the product.",
      "recall_initiation_date": "20150824",
      "center_classification_date": "20150922",
      "termination_date": "20170419",
      "report_date": "20150930",
      "code_info": "Lot #: 86430, Exp 09/17; 87806, Exp 02/18; 88147, Exp 03/18"
    }
  ]
}